Literature DB >> 9525823

Experimental cisplatin neuronopathy in rats and the effect of retinoic acid administration.

G Tredici1, S Tredici, D Fabbrica, C Minoia, G Cavaletti.   

Abstract

Peripheral nervous system alterations were induced in adult rats by administration of cisplatin (CDDP) 2 mg/kg twice weekly for 4.5 weeks. Dorsal root ganglion neurons showed pathological changes. Morphometric determinations demonstrated a reduction in size of the somatic, nuclear and nucleolar area. The nucleoli were the most involved subcellular structures. Nerve conduction velocity and the tail-flick test for pain were both significantly altered in CDDP treated rats, whereas the rota-rod test for coordination revealed no changes in either treated or control rats. Analytical determinations demonstrated platinum accumulation in the DRG of CDDP treated rats. Spontaneous recovery, demonstrated by morphometric, electrophysiological, functional and analytical determinations, occurred after treatment discontinuation within about 7 weeks. A pilot study of the possible neuroprotective action of retinoic acid (RA) was also performed with this model of cisplatin neuronopathy. The rationale for using RA was based on its assumed antioxidant and neurotrophic effect. However, RA failed to prevent morphometric, electrophysiological, functional and analytical alterations induced by CDDP on DRG neurons. RA induced only a mild generalized protective effect.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9525823     DOI: 10.1023/a:1005756023082

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  54 in total

1.  Chemical reactivity of cisplatin bound to human plasma proteins.

Authors:  L Hegedüs; W J van der Vijgh; I Klein; S Kerpel-Fronius; H M Pinedo
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

Review 2.  The role of glutathione in combination with cisplatin in the treatment of ovarian cancer.

Authors:  M Tedeschi; A De Cesare; S Oriana; P Perego; A Silva; P Venturino; F Zunino
Journal:  Cancer Treat Rev       Date:  1991-12       Impact factor: 12.111

Review 3.  The potential for treating neurodegenerative disorders with NGF-inducing compounds.

Authors:  S Carswell
Journal:  Exp Neurol       Date:  1993-11       Impact factor: 5.330

4.  Permeation of proteins from the blood into peripheral nerves and ganglia.

Authors:  D T Allen; J A Kiernan
Journal:  Neuroscience       Date:  1994-04       Impact factor: 3.590

Review 5.  Fundamental studies with cisplatin.

Authors:  B Rosenberg
Journal:  Cancer       Date:  1985-05-15       Impact factor: 6.860

6.  Retinoids increase perinatal spinal cord neuronal survival and astroglial differentiation.

Authors:  L Wuarin; N Sidell; J de Vellis
Journal:  Int J Dev Neurosci       Date:  1990       Impact factor: 2.457

Review 7.  Binding of the antitumor drug cis-diamminedichloroplatinum(II) (cisplatin) to DNA.

Authors:  A L Pinto; S J Lippard
Journal:  Biochim Biophys Acta       Date:  1985

8.  Solution structure of a cisplatin-induced DNA interstrand cross-link.

Authors:  H Huang; L Zhu; B R Reid; G P Drobny; P B Hopkins
Journal:  Science       Date:  1995-12-15       Impact factor: 47.728

9.  An ultrastructural study of neuronal changes in dorsal root ganglia (DRG) of rats after chronic cisplatin administrations.

Authors:  R Cece; M G Petruccioli; G Cavaletti; I Barajon; G Tredici
Journal:  Histol Histopathol       Date:  1995-10       Impact factor: 2.303

10.  Cisplatin-induced peripheral neurotoxicity is dependent on total-dose intensity and single-dose intensity.

Authors:  G Cavaletti; L Marzorati; G Bogliun; N Colombo; M Marzola; M R Pittelli; G Tredici
Journal:  Cancer       Date:  1992-01-01       Impact factor: 6.860

View more
  13 in total

Review 1.  Inflammation and cancer-related fatigue: mechanisms, contributing factors, and treatment implications.

Authors:  Julienne E Bower; Donald M Lamkin
Journal:  Brain Behav Immun       Date:  2012-07-06       Impact factor: 7.217

2.  Cannabinoid type-1 receptor reduces pain and neurotoxicity produced by chemotherapy.

Authors:  Iryna A Khasabova; Sergey Khasabov; Justin Paz; Catherine Harding-Rose; Donald A Simone; Virginia S Seybold
Journal:  J Neurosci       Date:  2012-05-16       Impact factor: 6.167

Review 3.  Chemotherapy-induced painful neuropathy: pain-like behaviours in rodent models and their response to commonly used analgesics.

Authors:  Holly L Hopkins; Natalie A Duggett; Sarah J L Flatters
Journal:  Curr Opin Support Palliat Care       Date:  2016-06       Impact factor: 2.302

4.  Analgesic effects of clinically used compounds in novel mouse models of polyneuropathy induced by oxaliplatin and cisplatin.

Authors:  Jennifer R Deuis; Yu Ling Lim; Silmara Rodrigues de Sousa; Richard J Lewis; Paul F Alewood; Peter J Cabot; Irina Vetter
Journal:  Neuro Oncol       Date:  2014-04-08       Impact factor: 12.300

5.  Neurotoxicity of platinum compounds: comparison of the effects of cisplatin and oxaliplatin on the human neuroblastoma cell line SH-SY5Y.

Authors:  Elisabetta Donzelli; Maria Carfì; Mariarosaria Miloso; Alberto Strada; Stefania Galbiati; Martine Bayssas; Genevieve Griffon-Etienne; Guido Cavaletti; Maria Grazia Petruccioli; Giovanni Tredici
Journal:  J Neurooncol       Date:  2004 Mar-Apr       Impact factor: 4.130

Review 6.  Animal models of chemotherapy-evoked painful peripheral neuropathies.

Authors:  Nicolas Authier; David Balayssac; Fabien Marchand; Bing Ling; Aude Zangarelli; Juliette Descoeur; François Coudore; Emmanuel Bourinet; Alain Eschalier
Journal:  Neurotherapeutics       Date:  2009-10       Impact factor: 7.620

7.  Erythropoietin both protects from and reverses experimental diabetic neuropathy.

Authors:  Roberto Bianchi; Belgin Buyukakilli; Michael Brines; Costanza Savino; Guido Cavaletti; Norberto Oggioni; Giuseppe Lauria; Monica Borgna; Raffaella Lombardi; Burak Cimen; Ulku Comelekoglu; Arzu Kanik; Cengiz Tataroglu; Anthony Cerami; Pietro Ghezzi
Journal:  Proc Natl Acad Sci U S A       Date:  2004-01-12       Impact factor: 11.205

8.  Behavioral and electrophysiological studies in rats with cisplatin-induced chemoneuropathy.

Authors:  Juan P Cata; Han-Rong Weng; Patrick M Dougherty
Journal:  Brain Res       Date:  2008-07-15       Impact factor: 3.252

Review 9.  Methods for in vivo studies in rodents of chemotherapy induced peripheral neuropathy.

Authors:  Jordi Bruna; Paola Alberti; Aina Calls-Cobos; Martial Caillaud; M Imad Damaj; Xavier Navarro
Journal:  Exp Neurol       Date:  2019-12-15       Impact factor: 5.330

10.  Impact of cisplatin administration on cerebellar cortical structure and locomotor activity of infantile and juvenile albino rats: the role of oxidative stress.

Authors:  Hanan E L Mokhtar; Mohey A E Hulail; Samar Mortada Mahmoud; Doaa Mohammed Yousef
Journal:  Anat Sci Int       Date:  2021-08-13       Impact factor: 1.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.